以晕厥就诊患者负荷心肌灌注显像:PET与SPECT比较
该研究纳入2010年1月至2016年12月间1324例无已知冠心病(CAD)的晕厥患者,分别接受PET(n=640)或SPECT(n=684)心肌灌注显像(MPI)。PET组异常MPI比例36.5%(201/551)高于SPECT组13.0%(87/671)(P<0.001),但主要与PET人群合并症负担和验前CAD风险更高有关。作者结论认为MPI价值与验前风险相关而非晕厥本身,低风险人群行PET或SPECT MPI价值低。
要点
- 无已知CAD的晕厥患者中,PET组异常MPI 36.5%(201/551)高于SPECT组13.0%(87/671)(P<0.001)。
- 接受冠状动脉造影者中,PET组8.5%(47/551)、SPECT组0.7%(5/671)发现梗阻性CAD。
- 中等-高验前风险者异常MPI和梗阻性CAD比例高于低风险者,PET与SPECT队列均如此。
核心结论
- 在中等-高验前CAD风险并因晕厥转诊行PET MPI的患者中,约三分之一存在异常MPI,约十分之一存在梗阻性CAD。
- MPI的价值与验前风险相关而非晕厥本身,低风险人群行PET或SPECT MPI价值低。
研究设计与样本
- 2010年1月至2016年12月连续纳入1324例无已知CAD的晕厥患者,接受PET(n=640)或SPECT(n=684)MPI。
- 按验前风险分层比较异常MPI比例,并在转诊冠状动脉造影者中计算梗阻性CAD诊断率,另设倾向匹配的无晕厥对照队列比较。
主要发现
- PET组异常MPI 36.5%(201/551) vs SPECT组13.0%(87/671)(P<0.001),主要与PET人群合并症负担更高和验前CAD风险更高有关。
- 异常MPI者中,转诊冠状动脉造影发现梗阻性CAD者为PET组8.5%(47/551) vs SPECT组0.7%(5/671)。
- 中等-高验前风险者在PET和SPECT队列中异常MPI比例和梗阻性CAD比例均高于低风险者。
- 匹配后晕厥与非晕厥患者PET MPI异常率及诊断率相似,且与验前概率成比例。
关键数值与推荐
- PET异常MPI定义: summed difference score(SDS)>2或左心室射血分数(LVEF)储备≤0;SPECT异常MPI定义:SDS>2或负荷后LVEF≤45%。
局限性
- PET与SPECT两组异常MPI差异主要与PET人群合并症负担更高和验前CAD风险更高有关,非随机比较。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The role of myocardial perfusion imaging (MPI) in patients with suspected coronary artery disease (CAD) presenting with syncope is controversial. We aimed to determine diagnostic yield of MPI for evaluation of syncope in patients without known CAD, as a function of pre-test patient risk and test modality (PET vs SPECT). METHODS: Between 1/2010 and 12/2016, 1324 consecutive patients presenting with syncope without known CAD underwent MPI with PET (n = 640) or SPECT (n = 684). Rates of abnormal MPI (summed difference score (SDS) > 2 or left ventricular ejection fraction (LVEF) reserve ≤ 0 for PET and SDS > 2 or post-stress LVEF ≤ 45% for SPECT) were determined among patients stratified by pre-test risk. In patients who were referred for coronary angiography, diagnostic yield of obstructive CAD was calculated in the overall cohort as well as in a propensity-matched cohort compared to patients without syncope. RESULTS: Abnormal MPI was noted in 36.5% (201/551) of patients who had PET compared with 13.0% (87/671) who had SPECT (P < 0.001), which is largely related to higher comorbidity burden and greater pre-test CAD risk in the PET population. Among patients who had an abnormal MPI, 8.5% (47/551) with PET and 0.7% (5/671) with SPECT were found to have obstructive CAD if referred for coronary angiography. Patients at intermediate-high pre-test risk had a higher proportion of abnormal MPIs and obstructive CAD as compared to those at low risk in both the PET and SPECT cohorts. The rate of abnormal testing and diagnostic yield of PET MPI was similar and proportionate to pre-test likelihood among matched patients with and without syncope. CONCLUSIONS: Among patients referred for PET MPI with syncope at an intermediate-high pre-test CAD risk, 1 in 3 had an abnormal MPI and 1 in 10 had obstructive CAD. The value of MPI was related to pre-test risk as opposed to the presence of syncope, and MPI testing with PET or SPECT in the low-risk population was low value.
引用
- Thomas M, Patel KK, Peri-Okonny P, et al. Stress myocardial perfusion imaging in patients presenting with syncope: Comparison of PET vs. SPECT. J Nucl Cardiol. 2020. PMID: 32405986. doi:10.1007/s12350-020-02179-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。